Cancer drug may be helpful for diabetes - KCBD NewsChannel 11 Lubbock

Cancer drug may be helpful for diabetes

Updated:
© iStockphoto.com / Dr. Heinz Linke © iStockphoto.com / Dr. Heinz Linke
  • HealthMore>>

  • The 'Hobby Lobby ruling' and what it means for U.S. health care

    The 'Hobby Lobby ruling' and what it means for U.S. health care

    The U.S. Supreme Court's ruling on contraception coverage -- as mandated under the Affordable Care Act -- could lead to a legal quagmire that might allow companies to deny insurance coverage for any medical practice that violates their religious principles.
    The U.S. Supreme Court's ruling on contraception coverage -- as mandated under the Affordable Care Act -- could lead to a legal quagmire that might allow companies to deny insurance coverage for any medical practice that violates their religious principles.
  • Diet changes can alter gut bacteria

    Diet changes can alter gut bacteria

    Dietary changes can dramatically alter the balance of bacteria in the gut on a daily basis, according to a new study.
    Dietary changes can dramatically alter the balance of bacteria in the gut on a daily basis, according to a new study.
  • Lift U.S. ban on blood donations by gay men

    Lift U.S. ban on blood donations by gay men

    The United States should repeal a 30-year policy that bans blood donations from gay and bisexual men, according to a team of medical and legal experts writing this week in the Journal of the American Medical...
    The United States should repeal a 30-year policy that bans blood donations from gay and bisexual men, according to a team of medical and legal experts writing this week in the Journal of the American Medical Association.

SUNDAY, Sept. 15 (HealthDay News) -- The cancer drug Zaltrap (aflibercept) could help treat diabetes, suggest findings from research using mice.

Scientists say they've identified a molecular pathway (a series of interactions among proteins) involved in the development of diabetes, and also found that the drug can regulate this pathway.

Zaltrap is approved in the United States to treat metastatic (spreading) colorectal cancer and the wet form of the eye disease macular degeneration. The drug inhibits the vascular endothelial growth factor (VEGF) pathway, thereby blocking the growth of blood vessels into tumors and starving them of oxygen.

The researchers, from the Stanford University School of Medicine, identified a series of proteins that link VEGF inhibitors and blood glucose levels.

"We were surprised to find that this drug currently used in patients for cancer treatment had beneficial effects on diabetes in laboratory mice and could, potentially, in humans," Dr. Calvin Kuo, a professor of medicine, said in a university news release.

Scientists caution, however, that research with animals often fails to provide similar results in humans.

"Proteins involved in this pathway could be targeted for the development of new diabetes therapies," Amato Giaccia, a professor of cancer biology and director of radiation oncology, said in the news release.

The findings appeared online Sept. 15 in two articles in the journal Nature Medicine.

The researchers said there have been indications that VEGF inhibitors such as Zaltrap could influence blood glucose levels in people, but no human studies have been conducted.

"Anecdotally, there have been reports that diabetic patients who have been prescribed VEGF inhibitors to treat their cancer are better able to control their diabetes," Kuo said.

Three co-authors of Kuo's study are employees at Regeneron Pharmaceuticals, which makes aflibercept.

More information

The U.S. National Institute of Diabetes and Digestive and Kidney Diseases has more about diabetes.

Copyright © 2013 HealthDay. All rights reserved.

*DISCLAIMER*: The information contained in or provided through this site section is intended for general consumer understanding and education only and is not intended to be and is not a substitute for professional advice. Use of this site section and any information contained on or provided through this site section is at your own risk and any information contained on or provided through this site section is provided on an "as is" basis without any representations or warranties.
Powered by WorldNow

5600 Avenue A
Lubbock, TX. 79404

FCC Public File
publicfile@kcbd.com
806-744-1414
EEO Report
Closed Captioning

All content © Copyright 2000 - 2014 Worldnow and KCBD. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.